Anbioton has been acquired by Elfa Medicamentos
The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.
Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.
Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.
One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.
Contacter l'équipe de la transaction
Transactions connexes
Dania Software has been acquired by Omnidocs
The owners of Dania Software A/S have sold the company to Omnidocs.
En apprendre plusTop Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider
Holland Capital, a Netherlands-based private equity firm, has acquired a stake in Top Systems, a leading provider of complete battery-based power solutions, with a unique value-added services proposition.
En apprendre plusSoler & Palau Ventilation has acquired subsidiaries of United Enertech Holdings
Soler & Palau Ventilation, Inc. (S&P) has acquired subsidiaries of United Enertech Holdings, LLC. (UEH). The subsidiaries included Air Conditioning Products, LLC; Air Performance, LLC; Metal Form Manufacturing, LLC; and United Enertech Corp.
En apprendre plus